Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 24,658 | 178 | 241 | 243 | 261 |
| Gross Profit | 24,658 | 178 | 241 | 243 | 261 |
| Operating Expenses | 5,260 | 3,756 | 7,441 | 6,922 | 5,878 |
| Operating Income | 19,398 | -3,578 | -7,200 | -6,679 | -5,617 |
| Other Income | 1,894 | -385 | -2,431 | 4,129 | 1,486 |
| Pre-tax Income | 21,292 | -3,963 | -9,631 | -2,550 | -4,131 |
| Income Tax | 6,868 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 14,424 | -484 | -9,631 | -2,550 | -4,131 |
| Net Income | $14,424 | $-484 | $-9,631 | $-2,550 | $-4,131 |
| EPS Basic Total Ops | 88.00 | -2.00 | -61.00 | -18.00 | -31.00 |
| EPS Basic Continuous Ops | 87.73 | -1.88 | -60.94 | -18.10 | -31.35 |
| EPS Diluted Total Ops | 87.00 | -2.00 | -61.00 | -18.00 | -31.00 |
| EPS Diluted Continuous Ops | 87.46 | -1.88 | -60.94 | -18.10 | -31.35 |
| EBITDA(a) | $18,871 | $-3,658 | $-7,330 | $-6,683 | $-5,767 |